Obsessive-Compulsive Disorder Spectrum as a Scientific “Metaphor”

CNS Spectrums

Volumn 13, Issue S14, 2008, Pages 6-15

  Pallanti, Stefano ^a   Hollander, Eric ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN 1B RECEPTOR; SEROTONIN UPTAKE INHIBITOR; TRYPTOPHAN HYDROXYLASE; TRYPTOPHAN HYDROXYLASE 1; UNCLASSIFIED DRUG;

ARTICLE; BEHAVIOR DISORDER; BODY DYSMORPHIC DISORDER; BRAIN DYSFUNCTION; COMORBIDITY; COMPULSIVE HOARDING; EXCESSIVE BODY CONCERN; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GILLES DE LA TOURETTE SYNDROME; HABIT; HUMAN; OBSESSIVE COMPULSIVE DISORDER; ONSET AGE; PATHOLOGICAL GROOMING; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SOCIAL PHOBIA; SYMPTOMATOLOGY; TIC; TRICHOTILLOMANIA;

ADULT; ANXIETY DISORDERS; CAUDATE NUCLEUS; CHILD; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE IMAGING; METAPHOR; NERVE NET; OBSESSIVE-COMPULSIVE DISORDER; PHENOTYPE; RISK FACTORS; TIC DISORDERS;

EID: 55449092512     PISSN: 10928529     EISSN: 21656509     Source Type: Journal    
DOI: 10.1017/S1092852900026882     Document Type: Article

References (75)

1. Karno, M, Golding, JM, Sorenson, SB, Burnam, MA. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry. 1988; 45(12):1094–1099.
2. Rasmussen, SA, Eisen, JL. Epidemiology of obsessive compulsive disorder. J Clin Psychiatry. 1990; 51(Suppl):10-3;discussion 14.
3. Zohar, J, Mueller, EA, Insel, TR, Zohar-Kadouch, RC, Murphy, DL. Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls. Arch Gen Psychiatry. 1987; 44(11):946–951.
4. Menzies, L, Chamberlain, SR, Laird, AR, Thelen, SM, Sahakian, BJ, Bullmore, ET. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev. 2008; 32(3):525–549.
5. An, SK, Mataix-Cols, D, Lawrence, NS, et al. To discard or not to discard: the neural basis of hoarding symptoms in obsessive-compulsive disorder. Mol Psychiatry. 2008 [Epub ahead of print].
6. Pato, MT, Hill, JL, Murphy, DL. A clomipramine dosage reduction study in the course of long-term treament of obsessive-compulsive disorder patients. Psychopharmacol Bull. 1990; 26(2):211–214
7. Baxter, LR. Brain imaging as a tool in establishing a theory of brain pathology in obsessive compulsive disorder. J Clin Psychiatry. 1990; 51(suppl):22–25;discussion 26.
8. Hollander, E, Stein, DJ, Decaria, CM, Cohen, L, Islam, M, Frenkel, M. Disorders related to OCD–neurobiology. Clin Neuropharmacol. 1992; 15(suppl 1 pt A):259A–260A.
9. Miguel, EC, Leckman, JF, Rauch, S, et al. Obsessive-compulsive disorder phenotypes: implications for genetic studies. Mol Psychiatry. 2005; 10(3):258–275.
10. Diagnostic and Statistical Manual of Mental Disorders. 4th ed, text revision. Washington, DC: American Psychiatric Association; 2000.
11. Stein, DJ, Lochner, C. Obsessive-compulsive spectrum disorders: a multidimensional approach. Psychiatr Clin North Am. 2006; 29(2):343–351.
12. Black, M. Models and Metaphors. Ithaca, NY: Cornell University Press; 1962.
13. Asimov, I. Profession. In: The Mammoth Book of Short Science Fiction Novels. Asimov, I, Greenburg, MH, Wuagh, CG. London: Robinson Publishing; 1986: 1–45.
14. Rosenblueth, A, Wiener, N. Purposeful and non-purposeful behavior. Philosophy of Science. 1950; 17: 318–326.
15. Janet, P. Les obsessions et la psychasthénie. 1903. Fdlix Alcan, Paris: Reprint: New York, NY: Arno Press; 1976.
16. Luys, M. Des Obsession pathologiques dans leur rapports avec l'activitè automatique des elements nerveux. Encephali. 1883; 3: 20–61.
17. Leckman, JF, Zhang, H. Symptom dimensions in obsessive-compulsive disorder: toward quantitative phenotypes. Am J Med Genet. 2001; 105(1):28–30.
18. Pertusa, A, Fullana, MA, Singh, S, Alonso, P, Menchówn, JM, Mataix-Cols, D. Compulsive hoarding: OCD symptom, distinct clinical syndrome, or both? Am J Psychiatry. 2008 [Epub ahead of print].
19. Rauch, SL, Shin, LM, Dougherty, DD, Alpert, NM, Fischman, AJ, Jenike, MA. Predictors of fluvoxamine response in contamination-related obsessive compulsive disorder: a PET symptom provocation study. Neuropsychopharmacology. 2002; 27(5):782–791.
20. Baer, L, Jenike, MA. Personality disorders in obsessive compulsive disorder. Psychiatr Clin North Am. 1992; 15(4):803–812.
21. Bienvenu, OJ, Samuels, JF, Riddle, MA, et al. The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiatry. 2000; 48(4):287–293.
22. Saxena, S, Brody, AL, Maidment, KM, et al. C erebral glucose metabolism in obsessive compulsive hoarding. Am J Psychiatry. 2004; 161(6):1038–1048.
23. Mataix-Cols, D, Rosario-Campos, MC. A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry. 2005; 162(2):228–238.
24. Skoog, G, Skoog, I. A 40-year follow-up of patients with obsessive-compulsive disorder. Arch Gen Psychiatry. 1999; 56(2):121–127.
25. Mataix-Cols, D, Rauch, SL, Baer, L, et al. Symptom stability in adult obsessive-compulsive disorder: data from a naturalistic two-year follow-up study. Am J Psychiatry. 2002; 159(2):263–268.
26. Rufer, M, Grothusen, A, Mass, R, Peter, H, Hand, I. Temporal stability of symptom dimensions in adult patients with obsessive-compulsive disorder. J Affect Disord. 2005; 88(1):99–102.
27. Pauls, DL, Alsobrook, JP 2nd, Goodman, W, et al. A family study of obsessive-compulsive disorder. Am J Psychiatry. 1995; 152(1):76–84.
28. Holzer, JC, Goodman, WK, McDougle, CJ, et al. Obsessive-compulsive disorder with and without a chronic tic disorder. A comparison of symptoms in 70 patients. Br J Psychiatry. 1994; 164(4):469–473.
29. Mathew, SJ, Coplan, JD, Perko, KA, et al. Neuroendocrine predictors of response to intravenous clomipramine therapy for refractory obsessive-compulsive disorder. Depress Anxiety. 2001; 14(4):199–208.
30. Storch, EA, Stigge-Kaufman, D, Marien, WE, et al. Obsessive-compulsive disorder in youth with and without a chronic tic disorder. Depress Anxiety. 2007 [Epub ahead of print].
31. Hoekstra, PJ, Minderaa, RB. Tic disorders and obsessive-compulsive disorder: is autoimmunity involved? Int Rev Psychiatry. 2005; 17(6):497–502.
32. Grados, MA, Mathews, CA, Tourette Syndrome Association International Consortium for Genetics. Latent Class Analysis of Gilles de la Tourette Syndrome Using Comorbidities: Clinical and Genetic Implications. Biol Psychiatry. 2008; 64(3):219–25.
33. Bloch, MH, Peterson, BS, Scahill, L, et al. Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome. Arch Pediatr Adolesc Med. 2006; 160(1):65–69.
34. Como, PG, LaMarsh, J, O’Brien, KA. Obsessive-compulsive disorder in Tourette's syndrome. Adv Neurol. 2005; 96: 249–261.
35. Diniz, JB, Rosario-Campos, MC, Hounie, AG, et al. Chronic tics and Tourette syndrome in patients with obsessive-compulsive disorder. J Psychiatr Res. 2006; 40(6):487–493.
36. Grados, M, Riddle, MA. Do all obsessive-compulsive disorder subtypes respond to medication? Int Rev Psychiatry. 2008; 20(2):189–193.
37. State, MW, Greally, JM, Cuker, A, et al. Epigenetic abnormalities associated with a chromosome 18(q21-q22) inversion and a Gilles de la Tourette syndrome phenotype. Proc Natl Acad Sci U S A. 2003; 100(8):4684–4689.
38. Walitza, S, Wewetzer, C, Gerlach, M, et al. Transmission disequilibrium studies in children and adolescents with obsessive-compulsive disorders pertaining to polymorphisms of genes of the serotonergic pathway. J Neural Transm. 2004; 111(7):817–825.
39. Walitza, S, Renner, TJ, Wewetzer, C, Warnke, A. Genetic findings in obsessive-compulsive disorder in childhood and adolescence and in adulthood. Z Kinder Jugendpsychiatr Psychother. 2008; 36(1):45–52.
40. Dickel, DE, Veenstra-VanderWeele, J, Bivens, NC, et al. Association studies of serotonin system candidate genes in early-onset obsessive-compulsive disorder. Biol Psychiatry. 2007; 61(3):322–329.
41. Bartz, JA, Hollander, E. Is obsessive-compulsive disorder an anxiety disorder? Prog Neuropsychopharmacol Biol Psychiatry. 2006; 30(3):338–352.
42. Fireman, B, Koran, LM, Leventhal, JL, Jacobson, A. The prevalence of clinically recognized obsessive-compulsive disorder in a large health maintenance organization. Am J Psychiatry. 2001; 158(11):1904–1910.
43. Nestadt, G, Samuels, J, Riddle, MA, et al. The relationship between obsessive-compulsive disorder and anxiety and affective disorders: results from the Johns Hopkins OCD Family Study. Psychol Med. 2001; 31(3):481–487.
44. LaSalle, VH, Cromer, KR, Nelson, KN, Kazuba, D, Justement, L, Murphy, DL. Diagnostic interview assessed neuropsychiatric disorder comorbidity in 334 individuals with obsessive-compulsive disorder. Depress Anxiety. 2004; 19(3):163–173.
45. Denys, D, Van Nieuwerburgh, F, Deforce, D, Westenberg, HG. Association between serotonergic candidate genes and specific phenotypes of obsessive compulsive disorder. J Affect Disord. 2006; 91(1):39–44.
46. Whiteside, SP, Port, JD, Abramowitz, JS. A meta-analysis of functional neuroimaging in obsessive-compulsive disorder. Psychiatry Res. 2004; 132(1):69–79.
47. Fineberg, NA and Gale, TM. Evidence-based pharmacotherapy of obsessive-compulsive disorder. Int J Neuropsychopharmacol. 2005; 8(1):107–129.
48. Goodman, WK, Lydiard, RB. Recognition and treatment of obsessive-compulsive disorder. J Clin Psychiatry. 2007; 68(12):e30.
49. Stein, DJ, Versiani, M, Hair, T, Kumar, R. Efficacy of paroxetine for relapse prevention in social anxiety disorder: a 24-week study. Arch Gen Psychiatry. 2002; 59(12):1111–1118.
50. Szeszko, PR, MacMillan, S, McMeniman, M, et al. Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive-compulsive disorder. Am J Psychiatry. 2004; 161(6):1049–1056.
51. Jenike, MA, Rauch, SL. Managing the patient with treatment-resistant obsessive compulsive disorder: current strategies. J Clin Psychiatry. 1994; 55(suppl):11–17.
52. Stein, DJ, Goodman, WK, Rauch, SL. The cognitive-affective neuroscience of obsessive-compulsive disorder. Curr Psychiatry Rep. 2000; 2(4):341–346.
53. First, MB, Pincus, HA, Levine, JB, Williams, JB, Ustun, B, Peele, R. Clinical utility as a criterion for revising psychiatric diagnoses. Am J Psychiatry. 2004; 161(6):946–954.
54. Hollander, E, Anagnostou, E, Chaplin, W, et al. Striatal volume on magnetic resonance imaging and repetitive behaviors in autism. Biol Psychiatry. 2005; 58(3):226–232.
55. Dale, RC. Autoimmunity and the basal ganglia: new insights into old diseases. QJM. 2003; 96(3):183–191.
56. Rauch, SL, Phillips, KA, Segal, E, et al. A preliminary morphometric magnetic resonance imaging study of regional brain volumes in body dysmorphic disorder. Psychiatry Res. 2003; 122(1):13–19.
57. Harel, Z, Hallett, J, Riggs, S, Vaz, R, Kiessling, L. Antibodies against human putamen in adolescents with anorexia nervosa. Int J Eat Disord. 2001; 29(4):463–469.
58. Wang, L, Lee, DY, Bailey, E, et al. Validity of large-deformation high dimensional brain mapping of the basal ganglia in adults with Tourette syndrome. Psychiatry Res. 2007; 154(2):181–190.
59. Saxena, S, Brody, AL, Schwartz, JM, Baxter, LR. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl. 1998;(35):26–37.
60. Leckman, JF. Tourette's syndrome. Lancet. 2002; 360: 1577–1586.
61. Peterson, BS, Skudlarski, P, Anderson, AW, et al. A functional magnetic resonance imaging study of tic suppression in Tourette syndrome. Arch Gen Psychiatry. 1998; 55(4):326–333.
62. Peterson, BS, Staib, L, Scahill, L, Zhang, H, Anderson, C, Leckman, JF, Cohen, DJ, Gore, JC, Albert, J, Webster, R. Regional brain and ventricular volumes in Tourette syndrome. Arch Gen Psychiatry. 2001; 58(5):427–440.
63. Peterson, BS, Thomas, P, Kane, MJ, et al. Basal Ganglia volumes in patients with Gilles de la Tourette syndrome. Arch Gen Psychiatry. 2003; 60(4):415–424.
64. Bloch, MH, Leckman, JF, Zhu, H, Peterson, BS. Caudate volumes in childhood predict symptom severity in adults with Tourette syndrome. Neurology. 2005; 65(8):1253–1258.
65. Swedo, SE, Leonard, HL, Rapoport, JL, Lenane, MC, Goldberger, EL, Cheslow, DL. A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling) N Engl J Med. 1989; 321(8):497–501.
66. Christenson, GA, Mackenzie, TB, Mitchell, JE, Callies, AL. A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania. Am J Psychiatry. 1991; 148(11):1566.
67. Ninan, PT, Rothbaum, BO, Marsteller, FA, Knight, BT, Eccard, MB. A placebo-controlled trial of cognitive-behavioral therapy and clomipramine in trichotillomania. J Clin Psychiatry. 2000; 61(1):47–50.
68. Bloch, MR, Elliott, M, Thompson, H, Koran, LM. Fluoxetine in pathologic skin-picking: open-label and double-blind results. Psychosomatics. 2001; 42(4):314–319.
69. Deckersbach, T, Wilhelm, S, Keuthen, NJ, Baer, L, Jenike, MA. Cognitive-behavior therapy for self-injurious skin picking. A case series. Behav Modif. 2002; 26(3):361–377.
70. Grant, JE, Mancebo, MC, Pinto, A, Eisen, JL, Rasmussen, SA. Impulse control disorders in adults with obsessive compulsive disorder. J Psychiatr Res. 2006; 40(6):494–501.
71. Phillips, KA. Body dysmorphic disorder: clinical aspects and treatment strategies. Bull Menninger Clin. 1998; 62(4 suppl A):A33–A48.
72. Eisen, JL, Phillips, KA, Coles, ME, Rasmussen, SA. Insight in obsessive compulsive disorder and body dysmorphic disorder. Compr Psychiatry. 2004; 45(1):10–15.
73. Phillips, KA, Grant, JE, Siniscalchi, JM, Stout, R, Price, LH. A retrospective follow-up study of body dysmorphic disorder. Compr Psychiatry. 2005; 46(5):315–321.
74. Rheaume, J, Freeston, MH, Dugas, MJ, Letarte, H, Ladouceur, R. Perfectionism, responsibility and obsessive-compulsive symptoms. Behav Res Ther. 1995; 33(7):785–794
75. Kendler, KS. Explanatory Models for Psychiatric Illness. Am J Psychiatry. 2008; 165(6):695–702.